If you’re in the life sciences industry, you understand the potential value of what you’re creating. That’s why it’s no surprise that the average cost of taking a drug to market is approaching $3 billion.1
The problem is that attackers understand the value, too. Clinical trial data, patient information, and years of IP make pharma and biotech particularly attractive targets for cyberattacks. And all of that valuable data has to move between people, partners, and systems to get a drug from lab to the patient, creating plenty of opportunities for something to go wrong.
A cyberattack in life sciences doesn’t stay an IT problem for long. Everything in the ecosystem has to be available and trustworthy, from research and clinical trial data to manufacturing environments and regulatory submissions. The investment behind a new drug, the rise in attacks, and the cost of a breach all point to the same thing: there’s a lot on the line.
And the costs are climbing. Ransomware attacks against healthcare-sector businesses, including pharmaceutical and medical manufacturers, jumped 25% in 2025.2 The healthcare sector, including pharma and biotech, faced average ransom demands nearly six times higher than the next-highest industry.3 And IBM puts the average cost of a pharmaceutical data breach rose from $4.61 million in 2025 to $5.25 million in 2026.4
But even that doesn’t capture the full impact of a breach to a business. How do you put a price on delaying a trial, research data that’s compromised, or IP that’s exposed to potential competitors? When so much of the business depends on the integrity of its data, the reach cost isn’t always the breach itself. It’s what the breach puts at risk.
It takes a lot of companies to bring a drug to market. Research teams work with contract research organizations (CROs), labs, manufacturers, technology vendors, and other partner. Individual interactions and teams form, all sharing data across their systems. No pharmaceutical or biotech preparation can make it to market without connections, but they also all widen the attack surface.
In life sciences, security has to work alongside compliance right from the start. Building for speed and adding validation later can mean paying twice: once to build and again to make it meet security and regulatory requirements.
That matters when it comes to R&D and clinical platforms, where access controls, audit trails, and change controls help protect regulated data and support requirements such as 21 CFR Part 11. In Good Manufacturing Practice (GMP) and OT, recovery has to protect data integrity and validated systems,. And for medical devices and digital health, security needs to be part of the product lifecycle.
A stronger approach brings those needs together: GXP–ready cloud infrastructure, 24/7 managed cybersecurity, governed data and AI platforms and IT operations that connect identity, endpoint security, backup, disaster recovery, configuration, and change management.
The goal is simple: build security, validation, and recovery in from the start rather than paying to add them later.
You don’t have to solve everything at once. Focus the next 90 days on four priorities.
Assess GxP cloud and IT readiness. Review validation documentation, access controls, audit trails, backup and disaster recovery, and 21 CFR Part 11 alignment across critical systems.
Strengthen 24/7 detection and response. Prioritize endpoints and identities connected to research, clinical, and manufacturing systems.
Put data governance around AI and analytics. Establish controls for sensitive data, access, consent, and monitoring .
Close computer system validation (CSV) gaps. Use risk-based validation to identify and address gaps across cloud and hybrid systems before your next submission or inspection.
NexusTek builds security, GxP, data integrity, and regulatory readiness into your environment right from the start. We design IT solutions across cloud, cybersecurity, AI, disaster recovery, and managed IT with GxP-trained teams to ensure your environment is validated right from R&D and through commercialization.
With 1,200+ active customers, 98% customer satisfaction, and 24/7/365 U.S-based support, NexusTek has the experience and resources to support you as you grow.
Ready to strengthen security and audit readiness without paying to rebuild later?
Start with a no-cost Life Sciences IT Readiness Assessment and get a prioritized roadmap of what to prioritize today.
Sources:
1. Deloitte, Navigating the GLP-1 Boom, May 2026
2. Comparitech.com, Healthcare Ransomware Roundup: 2025 stats on attacks, ransoms, and data breaches, January 2026
3. Becker’s Health IT, Healthcare ransomware demands average $18.2M: 7 notes, April 2026
4. IBM, Cost of a Data Breach Report 2026, August 2026
5. FDA, Innovative Technologies: What’s New, June 2025